DIPA applies analytics to validate protocol design decisions, identifying risks in consistency, patient burden, procedures, eligibility, and competitor benchmarks. Nearly 77% of protocols need amendments, adding $140K–$535K and three months per change. IQVIA’s review of 1,200+ draft protocols showed 90% of designs improved. By reducing non-core data, assessing criteria impact, and comparing with competitor trials, sponsors can minimize amendments, shorten timelines, and strengthen regulatory submissions. DIPA provides evidence-based insights that improve trial efficiency and success.

Join for free to read